AI Applications for Drug Discovery and Development is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Joseph Szustakowski
Executive Director at Bristol Myers Squibb

Profile

Dr. Joseph Szustakowski is the Executive Director and Head of Translational Bioinformatics at Bristol-Myers Squibb (BMS) where he leads a large team of computational biologists in the Translational Medicine division. Their work spans all therapeutic areas from discovery through clinical development.

Dr. Szustakowski received his undergraduate training in Physics (B.S.) and Mathematics at the State University of New York at Buffalo, and Biomedical Engineering (Ph.D.) at Boston University. While in graduate school, Joseph served as a member of the Human Genome Project’s annotation team.

Following graduate school, Joseph joined Novartis in Cambridge, Massachusetts, where he held positions with increasing responsibility ending with service as Associate Director for marker data sciences at before joining BMS in 2015. During his time at BMS, he has built up the Translational Bioinformatics team, which has become a leader in the application of Next Generation Sequencing and related -omics technologies in clinical trials.

Agenda Sessions

  • Discussion Panel: Challenges in the application of AI and Machine Learning in Drug Discovery - Different challenges for different entities

    ,